STH21643 IMPEDE-PKD Investigational Medicinal Product (IMP) Tender

  • Sheffield Teaching Hospitals NHS Foundation Trust

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-023185

Procurement identifier (OCID): ocds-h6vhtk-046f3b

Published 25 July 2024, 12:00pm



Section one: Contracting authority/entity

one.1) Name and addresses

Sheffield Teaching Hospitals NHS Foundation Trust

Royal Hallamshire Hospital, Glossop Road

Sheffield

S10 2JF

Contact

Andrew Duffield

Email

a.duffield1@nhs.net

Country

United Kingdom

Region code

UKE32 - Sheffield

Internet address(es)

Main address

https://www.sth.nhs.uk

Buyer's address

https://www.sth.nhs.uk


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

STH21643 IMPEDE-PKD Investigational Medicinal Product (IMP) Tender

Reference number

C289889

two.1.2) Main CPV code

  • 85149000 - Pharmacy services

two.1.3) Type of contract

Services

two.1.4) Short description

IMPEDE-PKD is a clinical trial looking to recruit 300 participants in the UK for a randomised placebo-controlled trial of Metformin XR 500mg. We are looking for bidders who have the capability to purchase or manufacture Metformin and an identical placebo, package and label them to our requirements and distribute to 35-40 NHS Trusts across the UK


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-023175


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

Please note amendment to II.2.5.1.1 - Award criteria.This should read Price is not the only award criterion and all criteria are stated only in the procurement documents